185
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Performance of Multidimensional Severity Scoring Systems in Patients with Post‐Tuberculosis Bronchiectasis

ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 2157-2165 | Published online: 14 Sep 2020

References

  • WHO. Global Tuberculosis Report 2019. Geneva: World Health Organization; 2020 Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1. Accessed 92, 2020.
  • RomanowskiK, BaumannB, BashamCA, Ahmad KhanF, FoxGJ, JohnstonJC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019. doi:10.1016/S1473-3099(19)30309-3
  • RavimohanS, KornfeldH, WeissmanD, BissonGP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018. doi:10.1183/16000617.0077-2017
  • PasipanodyaJG, MillerTL, VecinoM, et al. Pulmonary impairment after tuberculosis. Chest. 2007. doi:10.1378/chest.06-2949
  • RalphAP, KenangalemE, WaramoriG, et al. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One. 2013. doi:10.1371/journal.pone.0080302
  • MaguireGP, AnsteyNM, ArdianM, et al. Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting. Int J Tuberc Lung Dis. 2009;13:1500–1506.19919767
  • MeghjiJ, LesoskyM, JoekesE, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study. Thorax. 2020. doi:10.1136/thoraxjnl-2019-213808
  • MeghjiJ, SimpsonH, SquireSB, MortimerK. A systematic review of the prevalence and pattern of imaging defined post-TB lung disease. PLoS One. 2016. doi:10.1371/journal.pone.0161176
  • HuaGY, JieGW, XiaLS, et al. Aetiology of bronchiectasis in adults: a systematic literature review. Respirology. 2016. doi:10.1111/resp.12832
  • Al-JahdaliH, AlshimemeriA, MobeireekA, et al. The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis. Ann Thorac Med. 2017;12(3):135. doi:10.4103/atm.ATM_171_1728808486
  • ChalmersJD, GoeminneP, AlibertiS, et al. The Bronchiectasis Severity Index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–585. doi:10.1164/rccm.201309-1575OC24328736
  • Martínez-GarcíaMA, De GraciaJ, RelatMV, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43(5):1357–1367. doi:10.1183/09031936.0002631324232697
  • Rosales-MayorE, PolverinoE, RaguerL, et al. Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations. PLoS One. 2017;12(4):e0175171. doi:10.1371/journal.pone.017517128384311
  • Martinez-GarciaMA, AthanazioRA, GirónR, et al. Predicting high risk of exacerbations in bronchiectasis: the E-FACED score. Int J COPD. 2017;12:275–284. doi:10.2147/COPD.S121943
  • WangH, BinJX, LiCW, et al. Clinical characteristics and validation of bronchiectasis severity score systems for post-tuberculosis bronchiectasis. Clin Respir J. 2018. doi:10.1111/crj.12911
  • PasteurMC, BiltonD, HillAT. British thoracic society guideline for non-CF bronchiectasis. Thorax. 2010. doi:10.1136/thx.2010.142778
  • De SoyzaA, McDonnellMJ, GoeminnePC, et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study. Chest. 2017. doi:10.1016/j.chest.2016.12.024
  • PolverinoE, GoeminnePC, McDonnellMJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017. doi:10.1183/13993003.00629-2017
  • PasteurMC, HelliwellSM, HoughtonSJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000. doi:10.1164/ajrccm.162.4.9906120
  • DeLongER, DeLongDM, Clarke-PearsonDL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988. doi:10.2307/2531595
  • McDonnellMJ, AlibertiS, GoeminnePC, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016. doi:10.1136/thoraxjnl-2016-208481
  • EllisHC, CowmanS, FernandesM, WilsonR, LoebingerMR. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. Eur Respir J. 2016. doi:10.1183/13993003.01312-2015
  • AthanazioR, PereiraMC, GramblickaG, et al. Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts. BMC Pulm Med. 2017. doi:10.1186/s12890-017-0417-3
  • MenéndezR, MéndezR, PolverinoE, et al. Factors associated with hospitalization in bronchiectasis exacerbations: A one-year follow-up study. Respir Res. 2017. doi:10.1186/s12931-017-0659-x